Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.64 |
| ▸ | LPL | P06858 | 11/20 | 0.64 |
| ▸ | P4HB | P07237 | 1/20 | 0.39 |
| ▸ | F11 | P03951 | 2/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29892494 | 0.91 | LIPG (0.55) | LIPGLPLF11CA1CA2 | |
| SCHEMBL17940716 | 0.91 | LIPG (0.55) | LIPGLPLF11CA1CA2 | |
| SCHEMBL17120272 | 0.89 | LIPG (0.51) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL17940734 | 0.88 | LIPG (0.52) | LIPGLPLP4HBF11PRMT5 | |
| SCHEMBL24654364 | 0.88 | LIPG (0.77) | LIPGLPLP4HBF11DGAT1 | |
| SCHEMBL30009326 | 0.88 | LIPG (0.77) | LIPGLPLP4HBF11DGAT1 | |
| SCHEMBL14961217 | 0.86 | LPL (0.44) | LIPGLPLPDGFRBKDRPRMT5 | |
| SCHEMBL17120267 | 0.85 | LIPG (0.46) | LIPGLPLP4HBF11DGAT1 | |
| SCHEMBL17120273 | 0.84 | LIPG (0.64) | LIPGLPLDGAT1PRMT5WDR77 | |
| SCHEMBL23327819 | 0.83 | LIPG (0.64) | LIPGLPLP4HBDGAT1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10312451-B2 | Compound for organic electroluminescent device | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-06-04 | — | — | US | disclosed |
| US-10312451-B2 | Compound for organic electroluminescent device | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-06-04 | — | — | US | disclosed |
| CN-106748621-A | Organic compound and organic electroluminescent element using the same | 机光科技股份有限公司 | 2017-05-31 | — | — | CN | disclosed |
| US-20160218293-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-28 | — | — | US | disclosed |
| US-20160218293-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-28 | — | — | US | disclosed |
| US-20160218293-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10312451-B2 | Compound for organic electroluminescent device | ORAI2, TRPC6, ICMT | LIPG 1658/4885LPL 500/4885P4HB 4207/4885 |
| US-20160218293-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | ORAI2, TRPC6, ICMT | LIPG 1658/4885LPL 500/4885P4HB 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.